The Clinical Neuroscience Research program focuses on patient research. Funded researchers set up “controlled clinical studies” in a small number of patients with a specific brain disease, based on promising animal studies suggesting that a specific therapy either treated the condition or prevented it from getting worse. In these controlled clinical studies, the new therapy is tested in some of the patients while the other patients continue to receive currently available treatment. Through this process, clinical researchers determine whether the tested new therapy shows initial promise beyond currently available treatment.
Funding & Duration
Up to US $300,000 (approx. AUD $370,800) over three years.
Non-domestic (non-US) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Dates
- Applications may be submitted at any time.
- Please email firstname.lastname@example.org if you are considering applying for this scheme.
- Submit an Application to Research Services for Review